BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37478648)

  • 1. Body Mass Index and Pharmacologic Venous Thromboembolism Prophylaxis in Traumatic Brain Injury.
    Filiberto DM; Byerly S; Lenart EK; Fischer PE; Kerwin AJ
    J Surg Res; 2023 Nov; 291():245-249. PubMed ID: 37478648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin versus unfractionated heparin in pediatric traumatic brain injury.
    van Erp IA; Gaitanidis A; El Moheb M; Kaafarani HMA; Saillant N; Duhaime AC; Mendoza AE
    J Neurosurg Pediatr; 2021 Feb; 27(4):469-474. PubMed ID: 33578391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Thromboembolic Prophylaxis in Traumatic Brain Injuries: Low Molecular Weight Heparin Is Superior to Unfractionated Heparin.
    Benjamin E; Recinos G; Aiolfi A; Inaba K; Demetriades D
    Ann Surg; 2017 Sep; 266(3):463-469. PubMed ID: 28650361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism chemoprophylaxis in geriatric trauma patients with isolated severe traumatic brain injury.
    Condon F; Grigorian A; Russell D; Demetriades D
    Eur J Trauma Emerg Surg; 2024 Feb; 50(1):197-203. PubMed ID: 37306760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Venous Thromboembolism Prophylaxis After Neurosurgical Intervention for Traumatic Brain Injury With Thromboembolic Complications, Repeated Neurosurgery, and Mortality.
    Byrne JP; Witiw CD; Schuster JM; Pascual JL; Cannon JW; Martin ND; Reilly PM; Nathens AB; Seamon MJ
    JAMA Surg; 2022 Mar; 157(3):e215794. PubMed ID: 34910096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for thromboembolic complications in isolated severe head injury.
    Jakob DA; Müller M; Lewis M; Wong MD; Exadaktylos AK; Demetriades D
    Eur J Trauma Emerg Surg; 2024 Feb; 50(1):185-195. PubMed ID: 37289227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism prophylaxis in neurosurgical trauma patients.
    Tracy BM; Dunne JR; O'Neal CM; Clayton E
    J Surg Res; 2016 Sep; 205(1):221-7. PubMed ID: 27621023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of Pharmacologic Venous Thromboembolism Prophylaxis in Severe Traumatic Brain Injury: A Propensity-Matched Cohort Study.
    Byrne JP; Mason SA; Gomez D; Hoeft C; Subacius H; Xiong W; Neal M; Pirouzmand F; Nathens AB
    J Am Coll Surg; 2016 Oct; 223(4):621-631.e5. PubMed ID: 27453296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
    Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
    J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed prophylaxis with unfractionated heparin increases the risk of venous thromboembolic events in patients with moderate to severe traumatic brain injury: a retrospective analysis.
    Brandi G; Schmidlin A; Klinzing S; Schüpbach R; Unseld S; Pagnamenta A
    Anaesthesiol Intensive Ther; 2020; 52(1):28-33. PubMed ID: 32191827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprophylaxis for venous thromboembolism in pelvic and/or acetabular fractures: A systematic review.
    Shu HT; Yu AT; Lim PK; Scolaro JA; Shafiq B
    Injury; 2022 Apr; 53(4):1449-1454. PubMed ID: 35148902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower Mortality and Morbidity with Low-Molecular-Weight Heparin for Venous Thromboembolism Prophylaxis in Spine Trauma.
    Neifert SN; Chapman EK; Rothrock RJ; Gilligan J; Yuk F; McNeill IT; Rasouli JJ; Gal JS; Caridi JM
    Spine (Phila Pa 1976); 2020 Dec; 45(23):1613-1618. PubMed ID: 33156289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity weighted analysis of chemical venous thromboembolism prophylaxis agents in isolated severe traumatic brain injury: An EAST sponsored multicenter study.
    Ratnasekera AM; Seng SS; Kim D; Ji W; Jacovides CL; Kaufman EJ; Sadek HM; Perea LL; Poloni CM; Shnaydman I; Lee AJ; Sharp V; Miciura A; Trevizo E; Rosenthal MG; Lottenberg L; Zhao W; Keininger A; Hunt M; Cull J; Balentine C; Egodage T; Mohamed AT; Kincaid M; Doris S; Cotterman R; Seegert S; Jacobson LE; Williams J; Moncrief M; Palmer B; Mentzer C; Tackett N; Hranjec T; Dougherty T; Morrissey S; Donatelli-Seyler L; Rushing A; Tatebe LC; Nevill TJ; Aboutanos MB; Hamilton D; Redmond D; Cullinane DC; Falank C; McMellen M; Duran C; Daniels J; Ballow S; Schuster KM; Ferrada P
    Injury; 2024 Apr; ():111523. PubMed ID: 38614835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial Distribution and Associated Outcomes for Patients With and Without Severe-Isolated Traumatic Brain Injuries Following Venous Thromboembolism Prophylaxis.
    Elkbuli A; Patel H; Breeding T; Nasef H; Chin B; Wright DD; Zito T; Poulin SR; Rhodes-Lyons HX
    Am Surg; 2024 May; 90(5):969-977. PubMed ID: 38053263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin is associated with lower venous thromboembolism events than factor Xa inhibitors in patients with severe blunt trauma: a cohort study from the Trauma Quality Improvement Program.
    Chan SY; Huang JF; Cheng CT; Hsu CP; Liao CH; Fu CY
    Int J Surg; 2024 Jan; 110(1):280-286. PubMed ID: 37738013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Early Chemoprophylaxis in Traumatic Brain Injury and Risk of Venous Thromboembolism.
    Shulkosky MM; Han EJ; Wahl WL; Hecht JP
    Am Surg; 2023 Jun; 89(6):2513-2519. PubMed ID: 35575013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
    Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
    J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
    Marciniak CM; Kaplan J; Welty L; Chen D
    PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
    Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
    J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.